| Trial ID: | L0355 |
| Source ID: | NCT02654977
|
| Associated Drug: |
Metreleptin
|
| Title: |
CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT02654977/results
|
| Conditions: |
Familial Partial Lipodystrophy|Nonalcoholic Steatohepatitis|NAFLD
|
| Interventions: |
Drug: Metreleptin
|
| Outcome Measures: |
Percent Change in Fasting Triglyceride Levels|Percent Change in Hemoglobin A1c Levels
|
| Sponsor/Collaborators: |
University of Michigan
|
| Gender: |
All
|
| Age: |
5 Years and older ?? (Child, Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
11
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: N/A|Intervention Model: Single Group Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
September 29, 2015
|
| Completion Date: |
November 14, 2019
|
| Results First Posted: |
November 24, 2020
|
| Last Update Posted: |
November 24, 2020
|
| Locations: |
University of Michigan, Ann Arbor, Michigan, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT02654977
|
